8-K - Silence Therapeutics plc | StockGist

Current Report Details

Event Type

Management Change

Regulation Fd

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On December 1

Management Change

7.01

of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Ac

Regulation Fd

9.01

Exhibits. Exhibit Number Description 99.1 Press Release dated December 15, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1